BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38155245)

  • 21. NF-kappaB activation in premalignant mouse tal-1/scl thymocytes and tumors.
    O'Neil J; Ventura JJ; Cusson N; Kelliher M
    Blood; 2003 Oct; 102(7):2593-6. PubMed ID: 12816868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
    Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
    Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutting Edge: Lymphomyeloid-Primed Progenitor Cell Fates Are Controlled by the Transcription Factor Tal1.
    de Pooter RF; Dias S; Chowdhury M; Bartom ET; Okoreeh MK; Sigvardsson M; Kee BL
    J Immunol; 2019 May; 202(10):2837-2842. PubMed ID: 30962294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for E2-2 at the DN3 stage of early thymopoiesis.
    Wikström I; Forssell J; Penha-Goncalves MN; Bergqvist I; Holmberg D
    Mol Immunol; 2008 Jun; 45(11):3302-11. PubMed ID: 18384878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.
    Leong WZ; Tan SH; Ngoc PCT; Amanda S; Yam AWY; Liau WS; Gong Z; Lawton LN; Tenen DG; Sanda T
    Genes Dev; 2017 Dec; 31(23-24):2343-2360. PubMed ID: 29326336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
    Sanda T; Leong WZ
    Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.
    Fasseu M; Aplan PD; Chopin M; Boissel N; Bories JC; Soulier J; von Boehmer H; Sigaux F; Regnault A
    Blood; 2007 Oct; 110(7):2610-9. PubMed ID: 17507663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2A transcription factors limit expression of Gata3 to facilitate T lymphocyte lineage commitment.
    Xu W; Carr T; Ramirez K; McGregor S; Sigvardsson M; Kee BL
    Blood; 2013 Feb; 121(9):1534-42. PubMed ID: 23297135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression.
    Wojciechowski J; Lai A; Kondo M; Zhuang Y
    J Immunol; 2007 May; 178(9):5717-26. PubMed ID: 17442955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2A proteins enforce a proliferation checkpoint in developing thymocytes.
    Engel I; Murre C
    EMBO J; 2004 Jan; 23(1):202-11. PubMed ID: 14685278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2A/HEB and Id3 proteins control the sensitivity to glucocorticoid-induced apoptosis in thymocytes by regulating the SRG3 expression.
    Ko M; Ahn J; Lee C; Chung H; Jeon SH; Chung HY; Seong RH
    J Biol Chem; 2004 May; 279(21):21916-23. PubMed ID: 15016815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
    Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia.
    Ouyang K; Leandro Gomez-Amaro R; Stachura DL; Tang H; Peng X; Fang X; Traver D; Evans SM; Chen J
    Nat Commun; 2014 Sep; 5():4814. PubMed ID: 25215520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.
    Miyamoto A; Cui X; Naumovski L; Cleary ML
    Mol Cell Biol; 1996 May; 16(5):2394-401. PubMed ID: 8628307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
    Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
    Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB.
    Barndt RJ; Dai M; Zhuang Y
    Mol Cell Biol; 2000 Sep; 20(18):6677-85. PubMed ID: 10958665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.
    Yu S; Zhou X; Steinke FC; Liu C; Chen SC; Zagorodna O; Jing X; Yokota Y; Meyerholz DK; Mullighan CG; Knudson CM; Zhao DM; Xue HH
    Immunity; 2012 Nov; 37(5):813-26. PubMed ID: 23103132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.
    Zhong Y; Jiang L; Hiai H; Toyokuni S; Yamada Y
    Oncogene; 2007 Oct; 26(48):6937-47. PubMed ID: 17486074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
    Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
    Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice.
    Smith KS; Rhee JW; Naumovski L; Cleary ML
    Mol Cell Biol; 1999 Jun; 19(6):4443-51. PubMed ID: 10330184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.